LONDON, July 31 – British Swedish drugmaker AstraZeneca, which fought off a takeover from Pfizer earlier this year, raised its 2014 earnings outlook on Thursday and posted rising second quarter sales. Turnover gained four percent to $6.454 billion (4.819 billion euros) in the three months to June from a year earlier, aided by emerging markets […]
Read more here Capital Business
Read more here Capital Business